# SI-BONE, Inc.: filings

SIBN · Nasdaq · CIK 1459839 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sibn.md) · [Financials](/companies/sibn/financials.md) · [Filings](/companies/sibn/filings.md) · [Insiders](/companies/sibn/insiders.md)

## Reports and events: 111 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 450, 8-K 68, 144 56, 3 26, 10-Q 24, SC 13G/A 19, SC 13G 17, SCHEDULE 13G/A 10, CORRESP 9, S-8 9, UPLOAD 9, 10-K 8, DEF 14A 8, 424B5 6, D 5, DEFA14A 5, SCHEDULE 13G 5, ARS 4, DRS 3, EFFECT 3, S-3 3, S-3ASR 3, 4/A 2, DRS/A 2, RW 2, 10-Q/A 1, 144/A 1, 3/A 1, 424B4 1, 8-A12B 1, CERT 1, CT ORDER 1, DEFR14A 1, DRSLTR 1, PRE 14A 1, RW WD 1, S-1 1, S-1/A 1, S-1MEF 1, SUPPL 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-11 | 16:05 ET | [8-K](/filings/0001459839-26-000076.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001459839-26-000076 |
| 2026-08-04 | 16:13 ET | [10-Q](/filings/0001459839-26-000069.md) | Quarterly report, period 2026-06-30 | 0001459839-26-000069 |
| 2026-08-03 | 16:11 ET | [8-K](/filings/0001459839-26-000066.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001459839-26-000066 |
| 2026-06-08 | 16:09 ET | [8-K](/filings/0001459839-26-000059.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001459839-26-000059 |
| 2026-05-11 | 17:03 ET | [10-Q](/filings/0001459839-26-000056.md) | Quarterly report, period 2026-03-31 | 0001459839-26-000056 |
| 2026-05-11 | 16:11 ET | [8-K](/filings/0001459839-26-000054.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001459839-26-000054 |
| 2026-04-21 | 16:10 ET | [DEF 14A](/filings/0001459839-26-000049.md) | Proxy statement, period 2025-12-31 | 0001459839-26-000049 |
| 2026-02-24 | 16:19 ET | [10-K](/filings/0001459839-26-000036.md) | Annual report, period 2025-12-31 | 0001459839-26-000036 |
| 2026-02-23 | 16:11 ET | [8-K](/filings/0001459839-26-000022.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 5.02 Departure or appointment of officers or directors | 0001459839-26-000022 |
| 2026-01-12 | 09:11 ET | [8-K](/filings/0001459839-26-000010.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001459839-26-000010 |
| 2025-11-10 | 16:47 ET | [10-Q](/filings/0001459839-25-000095.md) | Quarterly report, period 2025-09-30 | 0001459839-25-000095 |
| 2025-11-10 | 16:12 ET | [8-K](/filings/0001459839-25-000094.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001459839-25-000094 |
| 2025-08-05 | 16:17 ET | [10-Q](/filings/0001459839-25-000076.md) | Quarterly report, period 2025-06-30 | 0001459839-25-000076 |
| 2025-08-04 | 16:11 ET | [8-K](/filings/0001459839-25-000073.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001459839-25-000073 |
| 2025-06-06 | 16:15 ET | [8-K](/filings/0001459839-25-000066.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001459839-25-000066 |
| 2025-05-06 | 16:05 ET | [10-Q](/filings/0001459839-25-000061.md) | Quarterly report, period 2025-03-31 | 0001459839-25-000061 |
| 2025-05-05 | 16:12 ET | [8-K](/filings/0001459839-25-000059.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001459839-25-000059 |
| 2025-04-25 | 16:08 ET | [DEF 14A](/filings/0001459839-25-000048.md) | Proxy statement, period 2024-12-31 | 0001459839-25-000048 |
| 2025-02-25 | 16:10 ET | [10-K](/filings/0001459839-25-000036.md) | Annual report, period 2024-12-31 | 0001459839-25-000036 |
| 2025-02-24 | 16:27 ET | [8-K](/filings/0001459839-25-000028.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001459839-25-000028 |
| 2025-01-13 | 09:05 ET | [8-K](/filings/0001459839-25-000005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001459839-25-000005 |
| 2024-11-12 | 17:00 ET | [10-Q](/filings/0001459839-24-000077.md) | Quarterly report, period 2024-09-30 | 0001459839-24-000077 |
| 2024-11-12 | 16:13 ET | [8-K](/filings/0001459839-24-000075.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001459839-24-000075 |
| 2024-08-06 | 16:15 ET | [10-Q](/filings/0001459839-24-000065.md) | Quarterly report, period 2024-06-30 | 0001459839-24-000065 |
| 2024-08-05 | 16:10 ET | [8-K](/filings/0001459839-24-000061.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001459839-24-000061 |
| 2024-07-19 | 16:03 ET | [8-K](/filings/0001459839-24-000055.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001459839-24-000055 |
| 2024-06-26 | 16:37 ET | [8-K](/filings/0001459839-24-000048.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001459839-24-000048 |
| 2024-05-07 | 16:06 ET | [10-Q](/filings/0001459839-24-000041.md) | Quarterly report, period 2024-03-31 | 0001459839-24-000041 |
| 2024-05-06 | 16:10 ET | [8-K](/filings/0001459839-24-000039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001459839-24-000039 |
| 2024-04-29 | 16:04 ET | [DEF 14A](/filings/0001459839-24-000031.md) | Proxy statement, period 2023-12-31 | 0001459839-24-000031 |
| 2024-02-27 | 16:03 ET | [10-K](/filings/0001459839-24-000014.md) | Annual report, period 2023-12-31 | 0001459839-24-000014 |
| 2024-02-26 | 16:10 ET | [8-K](/filings/0001459839-24-000010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001459839-24-000010 |
| 2024-01-08 | 08:31 ET | [8-K](/filings/0001459839-24-000003.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001459839-24-000003 |
| 2023-11-07 | 16:07 ET | [10-Q](/filings/0001459839-23-000105.md) | Quarterly report, period 2023-09-30 | 0001459839-23-000105 |
| 2023-11-06 | 16:10 ET | [8-K](/filings/0001459839-23-000102.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001459839-23-000102 |
| 2023-09-20 | 16:04 ET | [8-K](/filings/0001459839-23-000095.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001459839-23-000095 |
| 2023-08-08 | 16:08 ET | [10-Q](/filings/0001459839-23-000091.md) | Quarterly report, period 2023-06-30 | 0001459839-23-000091 |
| 2023-08-07 | 16:10 ET | [8-K](/filings/0001459839-23-000088.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001459839-23-000088 |
| 2023-06-12 | 16:04 ET | [8-K](/filings/0001459839-23-000083.md) | 5.07 Shareholder vote results | 0001459839-23-000083 |
| 2023-05-08 | 19:56 ET | [8-K](/filings/0001459839-23-000080.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001459839-23-000080 |
| 2023-05-02 | 16:24 ET | [10-Q](/filings/0001459839-23-000063.md) | Quarterly report, period 2023-03-31 | 0001459839-23-000063 |
| 2023-05-01 | 16:12 ET | [8-K](/filings/0001459839-23-000058.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001459839-23-000058 |
| 2023-04-21 | 16:27 ET | [DEF 14A](/filings/0001459839-23-000036.md) | Proxy statement, period 2023-04-21 | 0001459839-23-000036 |
| 2023-03-02 | 16:11 ET | [10-K](/filings/0001459839-23-000020.md) | Annual report, period 2022-12-31 | 0001459839-23-000020 |
| 2023-02-27 | 16:11 ET | [8-K](/filings/0001459839-23-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001459839-23-000014 |
| 2023-01-09 | 09:04 ET | [8-K](/filings/0001459839-23-000003.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001459839-23-000003 |
| 2022-11-08 | 16:07 ET | [10-Q](/filings/0001459839-22-000044.md) | Quarterly report, period 2022-09-30 | 0001459839-22-000044 |
| 2022-11-07 | 16:11 ET | [8-K](/filings/0001459839-22-000042.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001459839-22-000042 |
| 2022-08-09 | 16:05 ET | [10-Q](/filings/0001459839-22-000037.md) | Quarterly report, period 2022-06-30 | 0001459839-22-000037 |
| 2022-08-08 | 16:03 ET | [8-K](/filings/0001459839-22-000035.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001459839-22-000035 |

Page 1 of 3. [Older](/companies/sibn/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:22 ET. No prices; not investment advice.